This inventor holds 6 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Regents of the University of Minnesota, Mayo Foundation for Medical Education and Research. Active years: 2015-2025.
Company Filing History:
6 out of 2,367 
3 out of 1,805 
Years Active: 2015-2025
Title: Michael Anthony Walters: Innovator in Glaucoma Therapeutics
Introduction
Michael Anthony Walters is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of therapeutics, particularly in the treatment of glaucoma. With a total of 6 patents to his name, Walters has focused on developing innovative solutions to improve eye health.
Latest Patents
One of his latest patents involves the use of benzothiadiazine and chroman derivatives, specifically diazoxide and cromakalim derivatives, for treating glaucoma and related conditions. This invention aims to stabilize and inhibit blood and lymph vascularization while reducing intraocular pressure. By administering a pharmaceutically effective amount of a prodrug in an ophthalmically acceptable carrier, the treatment specifically modulates a K-channel to achieve its therapeutic effects.
Career Highlights
Throughout his career, Walters has worked with esteemed organizations such as the Regents of the University of Minnesota and the Mayo Foundation for Medical Education and Research. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Peter Dosa and Michael P. Fautsch. Their collaborative efforts have further advanced the research and development of innovative treatments in ophthalmology.
Conclusion
Michael Anthony Walters stands out as a dedicated inventor whose work in glaucoma therapeutics has the potential to significantly impact patient care. His innovative approaches and collaborations highlight the importance of research in advancing medical science.